Department of Biochemistry and Molecular Biophysics, Columbia University Medical Center, New York, NY 10032, USA; Department of Medicine, Division of Infectious Diseases, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.
J Glob Antimicrob Resist. 2021 Mar;24:90-92. doi: 10.1016/j.jgar.2020.11.005. Epub 2020 Nov 23.
Here we present a case series of three patients with COVID-19 (coronavirus disease 2019) who had a cytokine panel that revealed elevation of interleukin-6 (IL-6) but normal levels of interleukin-10 (IL-10), interferon-gamma (INF-γ) and interleukin-8 (IL-8), in contrast to the cytokine signature described in severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). We also documented evidence of a compromised T-cell IFN-γ response in two of these patients.
在这里,我们报告了三例 COVID-19(2019 年冠状病毒病)患者的病例系列,这些患者的细胞因子谱显示白细胞介素 6(IL-6)升高,但白细胞介素 10(IL-10)、干扰素-γ(INF-γ)和白细胞介素 8(IL-8)水平正常,与严重急性呼吸综合征(SARS)和中东呼吸综合征(MERS)中描述的细胞因子特征相反。我们还在其中两名患者中记录了 T 细胞 IFN-γ反应受损的证据。